140 295

Cited 0 times in

Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signalling pathway and subsequent suppression of nitric oxide production in macrophages.

Authors
Hirasawa, K; Jun, HS; Han, HS; Zhang, ML; Hollenberg, MD; Yoon, JW
Citation
Journal of virology, 73(10):8541-8548, 1999
Journal Title
Journal of virology
ISSN
0022-538X1098-5514
Abstract
Macrophages comprise the major population of cells infiltrating pancreatic islets during the early stages of infection in DBA/2 mice by the D variant of encephalomyocarditis virus (EMC-D virus). Inactivation of macrophages prior to viral infection almost completely prevents EMC-D virus-induced diabetes. This investigation was initiated to determine whether a tyrosine kinase signalling pathway might be involved in the activation of macrophages by EMC-D virus infection and whether tyrosine kinase inhibitors might, therefore, abrogate EMC-D virus-induced diabetes in vivo. When isolated macrophages were infected with EMC-D virus, inducible nitric oxide synthase mRNA was expressed and nitric oxide was subsequently produced. Treatment of macrophages with the tyrosine kinase inhibitor tyrphostin AG126, but not tyrphostin AG556, prior to EMC-D virus infection blocked the production of nitric oxide. The infection of macrophages with EMC-D virus also resulted in the activation of the mitogen-activated protein kinases (MAPKs) p42(MAPK/ERK2)/p44(MAPK/ERK1), p38(MAPK), and p46/p54(JNK). In accord with the greater potency of AG126 than of AG556 in blocking EMC-D virus-mediated macrophage activation, the incidence of diabetes in EMC-D virus-infected mice treated with AG126 (25%) was much lower than that in AG556-treated (75%) or vehicle-treated (88%) control mice. We conclude that EMC-D virus-induced activation of macrophages resulting in macrophage-mediated beta-cell destruction can be prevented by the inhibition of a tyrosine kinase signalling pathway involved in macrophage activation.
MeSH terms
AnimalsCardiovirus Infections/metabolism*Cardiovirus Infections/prevention & controlCells, CulturedDiabetes Mellitus, Type 1/metabolismDiabetes Mellitus, Type 1/prevention & controlDiabetes Mellitus, Type 1/virology*Enzyme Inhibitors/pharmacologyEnzyme Inhibitors/therapeutic useMacrophage Activation/drug effectsMacrophages, Peritoneal/metabolismMacrophages, Peritoneal/virology*Maus Elberfeld virus*MiceMice, Inbred DBANitric Oxide/antagonists & inhibitorsNitric Oxide/metabolism*Protein-Tyrosine Kinases/antagonists & inhibitorsProtein-Tyrosine Kinases/metabolism*Signal Transduction*/drug effectsTyrphostins/pharmacologyTyrphostins/therapeutic use
PMID
10482607
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Endocrinology & Metabolism
AJOU Authors
윤, 지원
Full Text Link
Files in This Item:
8541-8548.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse